☰

Ryan M. Franke, Ph.D. - Publications

Affiliations: 
University of California, Irvine, Irvine, CA 
Area:
Brain development, drug abuse, nicotine
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

4/27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Dwyer JB, Cardenas A, Franke RM, Chen Y, Bai Y, Belluzzi JD, Lotfipour S, Leslie FM. Prenatal nicotine sex-dependently alters adolescent dopamine system development. Translational Psychiatry. 9: 304. PMID 31740669 DOI: 10.1038/S41398-019-0640-1  0.582
2008 Franke RM, Park M, Belluzzi JD, Leslie FM. Prenatal nicotine exposure changes natural and drug-induced reinforcement in adolescent male rats. The European Journal of Neuroscience. 27: 2952-61. PMID 18588535 DOI: 10.1111/J.1460-9568.2008.06253.X  0.69
2007 Franke RM, Belluzzi JD, Leslie FM. Gestational exposure to nicotine and monoamine oxidase inhibitors influences cocaine-induced locomotion in adolescent rats. Psychopharmacology. 195: 117-24. PMID 17653695 DOI: 10.1007/S00213-007-0876-Y  0.642
2006 Leslie FM, Azam L, Gallardo K, O'Leary K, Franke R, Lotfipour S. Nicotinic Receptor Regulation of Developing Catecholamine Systems Brain Development: Normal Processes and the Effects of Alcohol and Nicotine. DOI: 10.1093/acprof:oso/9780195183139.003.0023  0.46
Low-probability matches (unlikely to be authored by this person)
2010 Franke RM, Gardner ER, Sparreboom A. Pharmacogenetics of drug transporters. Current Pharmaceutical Design. 16: 220-30. PMID 19835554 DOI: 10.2174/138161210790112683  0.118
2010 Lancaster CS, Hu C, Franke RM, Filipski KK, Orwick SJ, Chen Z, Zuo Z, Loos WJ, Sparreboom A. Cisplatin-induced downregulation of OCTN2 affects carnitine wasting. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 4789-99. PMID 20858838 DOI: 10.1158/1078-0432.Ccr-10-1239  0.11
2011 Eechoute K, Sparreboom A, Burger H, Franke RM, Schiavon G, Verweij J, Loos WJ, Wiemer EA, Mathijssen RH. Drug transporters and imatinib treatment: implications for clinical practice. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 406-15. PMID 21163869 DOI: 10.1158/1078-0432.CCR-10-2250  0.103
2022 Li Z, Franke RM, Morris DN, Yel L. Pharmacokinetics and Biochemical Efficacy of an α-Proteinase Inhibitor (Aralast NP) in α-Antitrypsin Deficiency: a Cross-Product Retrospective Comparability Analysis. Pulmonary Therapy. PMID 36001294 DOI: 10.1007/s41030-022-00199-4  0.094
2009 Baker SD, Verweij J, Cusatis GA, van Schaik RH, Marsh S, Orwick SJ, Franke RM, Hu S, Schuetz EG, Lamba V, Messersmith WA, Wolff AC, Carducci MA, Sparreboom A. Pharmacogenetic pathway analysis of docetaxel elimination. Clinical Pharmacology and Therapeutics. 85: 155-63. PMID 18509327 DOI: 10.1038/clpt.2008.95  0.09
2011 Franke RM, Lancaster CS, Peer CJ, Gibson AA, Kosloske AM, Orwick SJ, Mathijssen RH, Figg WD, Baker SD, Sparreboom A. Effect of ABCC2 (MRP2) transport function on erythromycin metabolism. Clinical Pharmacology and Therapeutics. 89: 693-701. PMID 21451505 DOI: 10.1038/Clpt.2011.25  0.089
2011 Eechoute K, Franke RM, Loos WJ, Scherkenbach LA, Boere I, Verweij J, Gurney H, Kim RB, Tirona RG, Mathijssen RH, Sparreboom A. Environmental and genetic factors affecting transport of imatinib by OATP1A2. Clinical Pharmacology and Therapeutics. 89: 816-20. PMID 21508937 DOI: 10.1038/clpt.2011.42  0.087
2009 Hu S, Chen Z, Franke R, Orwick S, Zhao M, Rudek MA, Sparreboom A, Baker SD. Interaction of the multikinase inhibitors sorafenib and sunitinib with solute carriers and ATP-binding cassette transporters. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 6062-9. PMID 19773380 DOI: 10.1158/1078-0432.Ccr-09-0048  0.085
2010 Franke RM, Sparreboom A. Drug transporters: recent advances and therapeutic applications. Clinical Pharmacology and Therapeutics. 87: 3-7. PMID 20019691 DOI: 10.1038/clpt.2009.239  0.08
2011 Walker AL, Franke RM, Sparreboom A, Ware RE. Transcellular movement of hydroxyurea is mediated by specific solute carrier transporters. Experimental Hematology. 39: 446-56. PMID 21256917 DOI: 10.1016/j.exphem.2011.01.004  0.076
2004 Franke R, Yang Y, Rubin LJ, Magliola L, Jones AW. High-fat diet alters K+-currents in porcine coronary arteries and adenosine sensitivity during metabolic inhibition. Journal of Cardiovascular Pharmacology. 43: 495-503. PMID 15085060 DOI: 10.1097/00005344-200404000-00004  0.065
2008 Hu S, Franke RM, Filipski KK, Hu C, Orwick SJ, de Bruijn EA, Burger H, Baker SD, Sparreboom A. Interaction of imatinib with human organic ion carriers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 3141-8. PMID 18483382 DOI: 10.1158/1078-0432.CCR-07-4913  0.064
2011 Sissung TM, Gardner ER, Piekarz RL, Howden R, Chen X, Woo S, Franke R, Clark JA, Miller-DeGraff L, Steinberg SM, Venzon D, Liewehr D, Kleeberger SR, Bates SE, Price DK, et al. Impact of ABCB1 allelic variants on QTc interval prolongation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 937-46. PMID 21106724 DOI: 10.1158/1078-0432.Ccr-10-0925  0.056
2008 Franke RM, Baker SD, Mathijssen RH, Schuetz EG, Sparreboom A. Influence of solute carriers on the pharmacokinetics of CYP3A4 probes. Clinical Pharmacology and Therapeutics. 84: 704-9. PMID 18509328 DOI: 10.1038/clpt.2008.94  0.054
2010 Franke RM, Carducci MA, Rudek MA, Baker SD, Sparreboom A. Castration-dependent pharmacokinetics of docetaxel in patients with prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 4562-7. PMID 20855838 DOI: 10.1200/Jco.2010.30.7025  0.054
2012 Ciarimboli G, Lancaster CS, Schlatter E, Franke RM, Sprowl JA, Pavenstädt H, Massmann V, Guckel D, Mathijssen RH, Yang W, Pui CH, Relling MV, Herrmann E, Sparreboom A. Proximal tubular secretion of creatinine by organic cation transporter OCT2 in cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 1101-8. PMID 22223530 DOI: 10.1158/1078-0432.Ccr-11-2503  0.048
2010 Franke RM, Kosloske AM, Lancaster CS, Filipski KK, Hu C, Zolk O, Mathijssen RH, Sparreboom A. Influence of Oct1/Oct2-deficiency on cisplatin-induced changes in urinary N-acetyl-beta-D-glucosaminidase. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 4198-206. PMID 20601443 DOI: 10.1158/1078-0432.Ccr-10-0949  0.039
2015 Franke RM, Morton T, Devarakonda K. Pooled post hoc analysis of population pharmacokinetics of oxycodone and acetaminophen following a single oral dose of biphasic immediate-release/extended-release oxycodone/acetaminophen tablets. Drug Design, Development and Therapy. 9: 4587-97. PMID 26316698 DOI: 10.2147/DDDT.S79499  0.039
2010 Eechoute K, Franke R, Loos W, de Bruijn P, Verweij J, Sparreboom A, Mathijssen R. 382 Influence of rosuvastatin on the pharmacokinetics of imatinib: a cross-over study European Journal of Cancer Supplements. 8: 121. DOI: 10.1016/S1359-6349(10)72089-9  0.038
2008 Franke RM, Sparreboom A. Inhibition of imatinib transport by uremic toxins during renal failure. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 4226-7; author reply. PMID 18757345 DOI: 10.1200/JCO.2008.18.4390  0.035
2015 Morton T, Franke R, Devarakonda K. Pooled Post Hoc Analysis of Population Pharmacokinetics of Oxycodone and Acetaminophen Following Multiple Oral Doses of Biphasic Immediate-Release/Extended-Release Oxycodone/Acetaminophen Tablets. Pain Practice : the Official Journal of World Institute of Pain. PMID 26218586 DOI: 10.1111/papr.12329  0.03
2022 Li Z, Franke RM, Morris D, Yel L. Comparative biochemical efficacy analysis of an alpha-proteinase inhibitor (Glassia®) in patients with alpha-1 antitrypsin deficiency. Pulmonary Pharmacology & Therapeutics. 102124. PMID 35314325 DOI: 10.1016/j.pupt.2022.102124  0.027
2009 Franke RM, Scherkenbach LA, Sparreboom A. Pharmacogenetics of the organic anion transporting polypeptide 1A2. Pharmacogenomics. 10: 339-44. PMID 19290786 DOI: 10.2217/14622416.10.3.339  0.023
Hide low-probability matches.